|
0
|
|
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.
(nejm.org)
|
Tolaney SM
…
Schmid P
New England Journal of Medicine
2026-01-22
|
#cancer
#clinical trial
#immunotherapy
#targeted therapy
|
|
0
|
|
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D.
(nejm.org)
|
Asselah T
…
Agarwal K
New England Journal of Medicine
2026-01-22
|
#infection
#immunotherapy
#hepatitis
#virologic
|
|
0
|
|
Nivolumab for Resected Stage III or IV Melanoma at 9 Years.
(nejm.org)
|
Ascierto PA
…
Larkin J
New England Journal of Medicine
2026-01-22
|
#immunotherapy
#melanoma
#survival
#checkpoint inhibitor
|
|
0
|
|
pTalpha enhances mRNA translation and potentiates CAR T cells for solid tumor eradication.
(linkinghub.elsevier.com)
|
Shi Y
…
Sadelain M
Cell
2026-01-22
|
#translation
#cancer
#persistence
#immunotherapy
#car t cells
|
|
0
|
|
Tumor-produced ammonia is metabolized by regulatory T cells to further impede anti-tumor immunity.
(linkinghub.elsevier.com)
|
Gu J
…
Lu L
Cell
2026-01-22
|
#metabolism
#immunosuppression
#transcriptomics
#cancer
#immunotherapy
|